ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
14 Mar 2016 Press Release: ESMO Appoints First Chief Medical Officer
04 Feb 2016 ESMO Press Release: World Cancer Day 2016 – ESMO and Patient Advocates, Together to Support Research Bioethics, legal and economic issues
02 Feb 2016 ESMO Press Release: Keith Hanson McGregor Appointed New ESMO CEO
19 Dec 2015 ESMO Asia 2015 Press Release: Afatinib a Better Choice for EGFR-Mutated Lung Cancer in First-Line Lung and other thoracic tumours - Anticancer agents & Biologic therapy
19 Dec 2015 ESMO Asia 2015 Press Release: More Patients with Lung Cancer Could Benefit from Immunotherapy, Study Shows Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
18 Dec 2015 ESMO Asia 2015 Press Release: Asian Women with Endocrine-Resistant Breast Cancer Benefit from Combination Therapy Breast cancer - Anticancer agents & Biologic therapy
17 Dec 2015 ESMO Asia 2015 Press Release: Immunotherapy and targeted therapy provide new options for difficult-to-treat head and neck cancer Head and neck cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
17 Dec 2015 ESMO Asia 2015 Press Release: Cancer drives patients to poverty in Southeast Asia Bioethics, legal and economic issues
16 Dec 2015 MEDIA ALERT: ESMO Asia 2015 Congress Preview
30 Sep 2015 ESMO Video Commentary: Nivolumab Benefit Continues in NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
29 Sep 2015 ESMO Commentary: New Promising Options are Available for Renal Cell Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
29 Sep 2015 ESMO Commentary: TOPGEAR results set to unify global treatment of gastric cancer Gastrointestinal cancers
29 Sep 2015 ESMO Commentary: Specialised staff required for the nutrition and family teams in supportive care Palliative and supportive care
28 Sep 2015 ESMO Commentary: Innovative approaches and drugs in early development phase show promising results in solid tumours Anticancer agents & Biologic therapy
28 Sep 2015 ESMO Commentary: A new promise for a rare skin cancer Cancer Immunology and Immunotherapy